NOVEL NEUROTRANSMITTERS-2 psychiatry ppt

susmitas1910 186 views 46 slides Jun 21, 2024
Slide 1
Slide 1 of 46
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46

About This Presentation

Novel neurotransmitter


Slide Content

NOVEL NEUROTRANSMITTERS PRESENTED BY DR JAYAKRISHNA CHAIRED BY DR ANJU MATHEW

NEUROTRANSMITTERS Chemicals that amplify or inhibit the depolarization signal from one neuron to that of adjacent neuron

Classical definition of neurotransmitter Synthesis in a presynaptic neuron Storage and release from a presynaptic neuron Binding to receptor on a post synaptic membrane Removal from synaptic cleft by reuptake and degradation

TYPES GASES ENDOCANNABINOIDS EICOSANOIDS N EUROSTEROIDS

NITRIC OXIDE

Mechanism Of Action of Nitric Oxide Cyclic GMP Pathway S- Nitrosylation pathway

cGMP Pathway

S- Nitrosylation Pathway

NITRIC OXIDE AND NEUROTRANSMISSION

NITRIC OXIDE AND BEHAVIOR Role in aggression Promotes REM sleep Innervate blood vessels of penis

NITRIC OXIDE AND MOOD DISORDERS SSRI inhibit NOS activity NO inhibit neurogenesis

NITRIC OXIDE AND SCHIZOPHRENIA Schizophrenia associated SNPs are found in CAPON (protein that associates with nNOS ) Autopsy samples-abnormally localized NOS expressing neurons in prefrontal cortex, hippocampus, lateral temporal lobe.

Neuropathologic roles of NO Protein Nitration Excitotoxicity- Ischaemic stroke Sporadic Parkinson disease( nitrosylate PARKIN—E3ubiquitin ligase) Nitrosylation of Protein disulfide isomerase…..in Alzheimer's disease

CARBON MONOXIDE Air pollutant Also physiologically produced

Enzymatic generation of CO

MOLECULAR ACTIONS OF CO Freely diffuse across cell membrane and activate guanylyl cyclase

CO and neurotransmission Odorant perception Adaptation to chronic pain GIT Role in ejaculation

Neuroprotective role of the hemeoxygenase pathway Impaired in Alzheimer’s disease

HYDROGEN SULPHIDE(H2S) Produced from cysteine and water Generated by two enzymes-CBS (cystathionine beta synthase) &CSE ( Cystathione gamma lyase). In brain CBS is abundant. In the brain H2S is at concentration as high as 160 micromolar=role in regulating brain function

FUNCTION OF H2S H2S potentiates NMDA receptor currents Can activate ATP sensitive potassium channels, dilate arterioles and increase activity of signaling kinase ERK

ENDOCANNABINOIDS Cannabinoids-active components of marijuana Endogenous cannabinoid/Endocannabinoids-endogenous brain ligand for CB1 receptor

Anandamide was the first endocannabinoid to be discovered. 2-arachidonyl glycerol(2-AG) N- arachidonyl dopamine(NADA) 2-arachidonyl glycerol ether( noladin ether) Virodhamine

BIOSYNTHESIS

Inactivation of endocannabinoids is by Fatty acid amide hydroxylase

Cannabinoid receptors CB1 Most abundant GPCRS in brain Highest density-cerebellum, basal ganglia, hippocampus, hypothalamus, cerebral cortex Presynaptic receptors CB 2 WBC (predominantly), brainstem

Effects on neurotransmission Inhibition of adenylyl cyclase-leads to decrease in Camp Activation of potassium channels and inhibition of N type calcium channels Activates mitogen activated protein kinase Inhibit release of GABA ,norepinephrine and acetyl choline Increase release of brain endorphin and dopamine in nucleus accumbens

Retrograde neurotransmission by endocannabinoids

Endocannabinoids in anxiety and mood Important regulator of anxiety Enhancing level of endocannabinoids may represent a therapeutic target for anxiety Mood disorders

ADDICTION Increases release of dopamine in nucleus accumbens -key reward area of brain implicated in addiction

PSYCHOSIS can produce psychotic symptoms Worsen schizophrenia Cannabinoid system appears to increase the release of dopamine

Endocannabinoids in brain injury and pain Neuroprotective Stress induced analgesia Endocannbinoids can promote analgesia via CB1 CB2 receptors but can increase pain via TRP channels

FEEDING Appetite stimulant CB1 receptor antagonist –Rimonabant for weight loss

Eicosanoids Eicosapentanoic acid Docosahexanoic acid Ethyl- eicosapentanoic acid

EFFECTS Protect neuron from inflammatory and oxidative toxicities Increases serotonin and dopamine Regulation of corticotrophin releasing factor

THERAPEUTIC INDICATIONS Negative correlation between fish consumption and mood disorder Adjunctive to Li ,significant improvement in Hamilton Rating Scale Low EPA and DHA high risk for post partum depression Consumption of DHA in pregnancy- increased problem solving skills in children

NEUROSTEROIDS Synthesized from cholesterol in the brain. Receptors are located on nucleus, membrane or microtubules of CNS and PNS. Most well known effect of neurosteroids is on the GABA-A receptor Act via a non genomic pathway to regulate neuronal excitability via their effects on the neurotransmitter gated ion channels

Act at GABA, NMDA, AMP, glycine, nicotinic acetyl choline receptor etc Egs -Allopregnanolone, pregnenolone, tetrahydrodeoxycorticosterone , progesterone Most prevalent neurosteroid -Dehydroepiandrosterone sulphate (DHEA)

FUNCTIONS Neurosteroids stimulate axonal growth and promote synaptic transmission Neuroprotective

Role of neurosteroids in mental illness DEPRESSION Antidepressants specially fluoxetine have been shown to increase the levels of neurosteroids ANXIETY DISORDER Homeostasis characterized by normal GABA ergic activity is restored after panic attacks as neurosteroids are released in response to stress

PSYCHOTIC DISORDERS DHEA-decrease anxiety in schizophrenia Decrease GABAergic transmission ADHD Clinical symptoms of ADHD are inversely correlated with DHEA and pregnenolone levels

Substance Abuse Alcohol can regulate GABA receptor and induce denovo steroid synthesis in brain Eating Disorder DHEA can decrease food intake, temper obesity, moderate insulin resistance, lower lipids by regulating serotonergic system

Postpartum Disorders Low post partum DHEA linked to mood instability Allopregnalone levels correlate with mood disorders in pregnancy and in PMS

Memory and Ageing DHEA supplementation can prevent or slow cognitive declines associated with ageing process Inconsistent evidence

SUMMARY Novel neurotransmitters don’t fit into the classical definition of neurotransmitters There are many types of novel neurotransmitters. They play an important role in various psychiatric disorders They are the potential targets for new drugs

REFERNCES Kaplan’s and Sadocks Comprehensive Text Book of Psychiatry Tenth Edition Novel neurotransmitters and their neuropsychiatric relevance;Solomon H et al; American Journal of Psychiatry 2000

THANK YOU
Tags